-+ 0.00%
-+ 0.00%
-+ 0.00%

Deqi Pharmaceutical announced that it has received an ATG-201 down payment of 60 million US dollars from Ushibi. The receipt of the down payment under this landmark agreement with Ushibi has further consolidated the Group's cash position and provided strong financial support to advance the development of the Group's innovative drug pipeline and accelerate the benefits of more patients.

Zhitongcaijing·07/13/2026 04:09:02
Listen to the news
Deqi Pharmaceutical announced that it has received an ATG-201 down payment of 60 million US dollars from Ushibi. The receipt of the down payment under this landmark agreement with Ushibi has further consolidated the Group's cash position and provided strong financial support to advance the development of the Group's innovative drug pipeline and accelerate the benefits of more patients.